Efficacy and Safety of Once-Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)

被引：0
|
作者：
Giorgino, Francesco
Benroubi, Maria
Sun, Jui-Hung
Zimmermann, Alan G.
Pechtner, Valeria
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
330-OR
引用
收藏
页码：A87 / A87
页数：1
相关论文
共 50 条
  • [21] Better Glycemic Control and Less Weight Gain with Once-Weekly Dulaglutide vs. Once-Daily Insulin Glargine, Both Combined with Premeal Insulin Lispro, in Type 2 Diabetes Patients (AWARD-4)
    Jendle, Johan
    Rosenstock, Julio
    Blonde, Lawrence
    Woo, Vincent
    Gross, Jorge
    Jiang, Honghua
    Milicevic, Zvonko
    DIABETES, 2014, 63 : A246 - A247
  • [22] Change in patient-reported outcomes (PROs) and the relationship with clinical parameters in patients with Type 2 diabetes receiving once weekly dulaglutide or insulin glargine in the Assessment of Weekly Administration of Dulaglutide in Diabetes (AWARD-2 and-4) studies
    Van Brunt, K.
    Adetunji, O.
    Yu, M.
    Boye, K. S.
    DIABETIC MEDICINE, 2015, 32 : 76 - 76
  • [23] Efficacy and safety of dulaglutide vs metformin in type 2 diabetes (AWARD-3)
    Tofe Povedano, S.
    Umpierrez, G.
    Perez Manghi, F.
    Shurzinske, L.
    Pechtner, V.
    DIABETOLOGIA, 2013, 56 : S8 - S8
  • [24] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [25] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
  • [26] Therapy in type 2 diabetes: Insulin glargine vs. 2 NPH insulin both in combination with glimepiride
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (04) : 495 - 501
  • [27] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Kuang, Jian
    Zhu, Jiankun
    Liu, Siying
    Li, Quanmin
    DIABETES THERAPY, 2020, 11 (10) : 2329 - 2339
  • [28] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Jian Kuang
    Jiankun Zhu
    Siying Liu
    Quanmin Li
    Diabetes Therapy, 2020, 11 : 2329 - 2339
  • [29] Patient-reported outcomes with once weekly dulaglutide versus placebo, both in combination with once daily insulin glargine ( plus /- metformin) in type 2 diabetes (AWARD-9)
    Yu, M.
    Van Brunt, K.
    Milicevic, Z.
    Varnado, O.
    Boye, K.
    DIABETOLOGIA, 2016, 59 : S383 - S384
  • [30] 1.5 Efficacy and Safety of Dulaglutide vs. Metformin in Type 2 Diabetes (AWARD-3) (69-OR)
    Guillermo E. Umpierrez
    Federico P. Manghi
    Santiago Tofe Povedano
    Linda Shurzinske
    Valeria Pechtner
    Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 78 - 78
12345